Health Care • Medical Specialities
$12.48 ▼ -0.38
(-2.95%)
MKT CAP: $1.38B • VOL: 651.2K
52W L $10 52W H $18
ROARABLE / RQD
D- • 36/100
PIOTROSKI
1 / 9
FRNM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $0 | $0 |
| YoY Revenue Growth % | — | — |
| Gross Profit | — | — |
| Gross Margin % | — | — |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$3.0M | $0 |
| Operating Margin % | — | — |
| Net Income (GAAP) | $837.5K | $0 |
| EBITDA (Normalized) | — | — |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$864.7K | — |
| Capital Expenditures (CapEx) | — | — |
| Free Cash Flow (FCF) | -$864.7K | — |
| FCF Margin % | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | — |
| Cash & Short-Term Equivalents | — | — |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | -$4.8M | -$2.1M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FRNM.